Astrana Health, Inc. (NASDAQ:ASTH) Shares Acquired by Victory Capital Management Inc.

Victory Capital Management Inc. lifted its position in Astrana Health, Inc. (NASDAQ:ASTH) by 38.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 62,116 shares of the company’s stock after acquiring an additional 17,310 shares during the period. Victory Capital Management Inc.’s holdings in Astrana Health were worth $1,959,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. increased its holdings in shares of Astrana Health by 5.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 471,329 shares of the company’s stock valued at $14,861,000 after purchasing an additional 23,533 shares during the period. US Bancorp DE boosted its position in Astrana Health by 3,880.0% in the fourth quarter. US Bancorp DE now owns 4,776 shares of the company’s stock valued at $151,000 after buying an additional 4,656 shares during the last quarter. Illinois Municipal Retirement Fund increased its holdings in Astrana Health by 16.8% in the 4th quarter. Illinois Municipal Retirement Fund now owns 24,987 shares of the company’s stock worth $788,000 after buying an additional 3,593 shares during the period. Olympiad Research LP purchased a new position in Astrana Health during the 4th quarter worth approximately $287,000. Finally, Hussman Strategic Advisors Inc. acquired a new stake in Astrana Health during the 4th quarter valued at approximately $1,986,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Price Performance

Shares of Astrana Health stock opened at $30.60 on Tuesday. The firm has a market cap of $1.72 billion, a PE ratio of 23.54, a P/E/G ratio of 1.37 and a beta of 1.30. Astrana Health, Inc. has a twelve month low of $23.12 and a twelve month high of $63.20. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The business has a 50-day moving average price of $33.95 and a 200 day moving average price of $42.95.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). The business had revenue of $665.21 million during the quarter, compared to analysts’ expectations of $617.24 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. Sell-side analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Bank of America reduced their target price on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a report on Tuesday, March 4th. Robert W. Baird reduced their price objective on Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. Truist Financial lowered their target price on Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday, January 13th. Macquarie upgraded Astrana Health to a “hold” rating in a research report on Monday, December 16th. Finally, Stifel Nicolaus lowered their price objective on Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Astrana Health presently has a consensus rating of “Moderate Buy” and an average price target of $56.83.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.